Symbol="NLTX"
AssetType="Common Stock"
Name="Neoleukin Therapeutics"
Description="Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmune disorders using protein design technology. The company is headquartered in Seattle, Washington."
CIK="1404644"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="SUITE 360 - 1616 EASTLAKE AVE EAST, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="31650100"
EBITDA="-52003000"
PERatio="None"
PEGRatio="None"
BookValue="1.9"
DividendPerShare="0"
DividendYield="0"
EPS="-1.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.27"
ReturnOnEquityTTM="-0.534"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="1.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.185"
EVToRevenue="-"
EVToEBITDA="1.31"
Beta="1.211"
num_52WeekHigh="1.34"
num_52WeekLow="0.375"
num_50DayMovingAverage="0.828"
num_200DayMovingAverage="0.651"
SharesOutstanding="42828300"
DividendDate="None"
ExDividendDate="None"
symbol="NLTX"
open="0.88"
high="0.88"
low="0.69"
price="0.74"
volume="3778523.00"
latest_trading_day="2023-07-18"
previous_close="0.93"
change="-0.19"
change_percent="-20.1081%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="6"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="94"
Volume_recent_avg="340308"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="0.53"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="94"
Aroon_momentum_negative="6"
image_negative_thumbnail_id_1="511"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0094.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="548"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_positive_thumbnail_id_1="685"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_positive_thumbnail_id_2="609"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
